Seth Klarman's position in Jazz Pharmaceuticals plc is currently worth $134 Million. That's 4.25% of their equity portfolio (8th largest holding). The investor owns 1.94% of the outstanding Jazz Pharmaceuticals plc stock. The investor's estimated purchase price is $165 Million, resulting in a loss of 19%.